Moore Australia (WA) client joins ASX with $6M IPO

Moore Australia

12 February 2021

Moore Australia congratulates client Singular Health, for making its debut on the ASX today.

“We are thrilled for Singular Health, and for being able to be part of their journey in listing today,” says Moore Australia (WA) Managing Partner, David Tomasi.

“The initial public offering (IPO) provides a perfect platform to launch future growth for Singular Health. With Singular Health’s future focus set on developing software and scaling its Volumetric Rendering Platform both locally and abroad, our Moore Global network is also pleased to assist them with their global expansion,” says David.

Moore Australia (WA) Partners, Neil Pace and Greg Godwin, led the client service team which provided audit related services, including an Independent Accountants Report for the ASX listing.

“It has been a pleasure working with Singular Health over the past year and being part of the team that has taken the Company to a listing on ASX,” says Neil.

Singular Health lodged its prospectus with the ASX in December 2020 but closed its initial IPO in January due to overwhelming investor support, where they were oversubscribed and raised $6 million. The prospectus shows the proceeds of the IPO will be used to assist Singular Health with its growth strategy and advancing its products.

Based in Subiaco, the four-year-old technology-driven medical imaging company’s primary focus is the development of medical software for the visualisation, manipulation, and transfer of medical imaging data. Its innovative patented software allows medical practitioners, patients, educators, and students the ability to view 2D medical images in 3D. The 3D model can then be viewed on a range of devices, from mobile phones, to workstations and virtual reality platforms.